Clinical Evaluation of Vanguard DD RP
← catalyst calendarSponsored by Zimmer Biomet (industry) · ZBH — their whole pipeline →.
Phase
Not applicable
Status
Active, not recruiting
Study type
Interventional
Design
Na · None · Treatment
Enrollment
113actual
Sites
1
Country
Austria
Every value on this page is a field the sponsor filed with ClinicalTrials.gov, reproduced. Dates are their own estimates, revised as a study runs, unless the registry marks them actual. sources →
Source: ClinicalTrials.gov, retrieved 2026-08-19
Dates
each axis at the precision it was filed, with the registry's own basis| Date | Filed | Basis | What it is |
|---|---|---|---|
| Start | 2013-07-11 | actual | When the study began enrolling |
| Primary completion | 2018-08-26 | actual | The date the last participant is measured for the primary outcome — the readout window |
| Study completion | 2026-12-31 | estimated | The whole study's end, after follow-up |
| First posted | 2019-09-03 | actual | When this record first appeared on the registry |
| Results posted | — | When the sponsor posted results to the registry | |
| Record updated | 2024-05-17 | actual | The sponsor's own last edit to this record — every projection above is as current as this date |
What it studies
Conditions
- Knee Osteoarthritis
- Post-traumatic Osteoarthritis
- Rheumatoid Arthritis
Intervention
- Device: Cementless Vanguard DD RP
Primary outcome
what the primary-completion date above is the date OFPerformance
measured 2 years
Permalink · ZBH's whole pipeline · Catalyst calendar · Every registered study · What changed